Weight-loss medications like Ozempic and Wegovy, which belong to the GLP-1 receptor agonist class of drugs, have gained massive popularity among adults, including celebrities, for their ability to aid weight loss. Recently, these medications have also gained traction among children and adolescents, sparking concerns and debates about their safety for younger populations.
The Rising Trend of GLP-1 Use in Children
Obesity is a growing concern, with about 1 in 5 children in the U.S. affected, according to the Centers for Disease Control and Prevention (CDC). Prescription rates for GLP-1 drugs have surged, with more than 30,000 adolescents aged 12-17 using these medications in 2023. The FDA has approved Wegovy, the weight-loss version of Ozempic, for use in children as young as 12. Research on the drug’s effectiveness for younger children is ongoing, and there have been studies on Saxenda (another GLP-1 drug) for children aged 6-12, which showed positive results.
While some healthcare providers are optimistic about early intervention for obesity, the safety and long-term effects of GLP-1 drugs on children remain uncertain.
Safety Concerns and Unknowns
Short-Term Efficacy vs. Long-Term Effects
Dr. Chris Straughn, a pediatrician, acknowledges that while GLP-1s can be effective for weight loss in kids, the research is still limited. We have data on their effects over a few years, but the longer-term implications are unknown.
Potential Impact During Development
Dr. Dan Cooper, a pediatric researcher, highlights the importance of puberty in a child’s development, particularly for bone mineralization, muscle growth, and brain development. He raises concerns that starting weight-loss drugs during this critical period might interfere with proper physical and cognitive development. This is especially worrisome considering that these drugs impact energy balance, which is a key factor during growth periods.
Psychological Effects
Another concern is the potential psychological impact of GLP-1 medications. Dr. Cooper advises parents to monitor their children for signs of depressive symptoms, as there is some concern that the drugs may trigger or worsen mental health issues.
When Do GLP-1 Medications Make Sense for Children?
There are specific cases where GLP-1 medications might be appropriate, such as for children with obesity-related health issues like diabetes. However, in the absence of such conditions, the risk-benefit analysis becomes more complex. The lack of long-term research on children means that pediatricians are still weighing the potential benefits and risks.
What Should Parents Do?
Parents should feel empowered to ask their children’s doctors about GLP-1 medications. If the drugs are prescribed, they should monitor their children closely and continue promoting healthy eating and active lifestyles. Parents should also avoid feelings of shame regarding obesity, as it’s largely influenced by biology, and they should refrain from blaming themselves or their children for their weight.
In summary, while GLP-1 medications may provide a viable weight loss solution for some children, they come with significant uncertainties. Doctors stress the importance of careful consideration, ongoing monitoring, and a balanced approach to ensure the well-being of children who are prescribed these medications.
Related Topics:
